68Ga-NOTA-AE105

DRUG3 trials

Sponsors

Rigshospitalet, Denmark

Conditions

Breast CancerHead and Neck CancerProstate Cancer

Phase 2

uPAR PET/CT for Preoperative Staging of Breast Cancer Patients

CompletedNCT02681640

Rigshospitalet, DenmarkBreast Cancer

Start: 2016-03-31End: 2017-03-31Updated: 2017-04-06

Phase II Trial: uPAR-PET/CT for Prognostication in Head- and Neck Cancer

CompletedNCT02965001

Rigshospitalet, DenmarkHead and Neck Cancer

Start: 2016-11-30End: 2021-12-31Updated: 2022-11-03

uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor Aggressiveness

Rigshospitalet, DenmarkProstate Cancer

Start: 2017-11-21End: 2022-04-01Updated: 2020-11-23

Related Papers

Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with <sup>18</sup>F-FDG PET/CT: A Single-Center Prospective Study

Journal of Nuclear Medicine2021-12-0217 citations